Skip to content

Debt-to-equity at other companies

Baxter International logo
Baxter InternationalBAX
0.0×
Boston Scientific logo
Boston ScientificBSX
-0.5×
Merit Medical Systems logo
Merit Medical SystemsMMSI
0.5×-0.1×
Medtronic logo
MedtronicMDT
0.6×0.0×
Abbott logo
AbbottABT
0.7×+0.4×
Cytokinetics logo
CytokineticsCYTK
2.2×

Other financials

Income statement

See full
Revenue$199.4M+25.7%
Gross profit$141.4M+29.4%
Operating income-$16.2M+50.3%
Net income-$13.9M+54.6%
EPS (diluted)-$0.43+55.7%

Balance sheet

See full
Cash & equivalents$248.5M-35.2%
Total debt$79.0M-10.5%
Total equity$161.2M+86.0%
Total assets$1.0B+8.7%

Cash flow

See full
Operating cash flow-$26.2M-232%
CapEx$6.9M-26.7%
Free cash flow-$33.1M-91.1%

Valuation

See full
Market cap$3.44B+16.0%
Enterprise value$3.27B+21.8%
P/S4.4×-0.4×

Profitability

See full
Gross margin71%+1.6pp
Operating margin-5.5%-2.2pp
Net margin-7.3%-3.1pp
FCF margin2.4%

Returns & leverage

See full
Return on equity-53.1%-17.4pp
Current ratio5.2×-0.5×

Where this comes from

Calculated from iRhythm Holdings, Inc. ’s reported figures.

Based on the most recent quarter.

The official record: iRhythm Holdings, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRhythm Holdings, Inc. 's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is iRhythm Holdings, Inc. 's debt-to-equity?
iRhythm Holdings, Inc. (IRTC) reported debt-to-equity of 0.5× in Q1 2026.
How has iRhythm Holdings, Inc. 's debt-to-equity changed year-over-year?
iRhythm Holdings, Inc. 's debt-to-equity decreased by 51.9% year-over-year, from 1× to 0.5×.
What is the long-term trend for iRhythm Holdings, Inc. 's debt-to-equity?
Over 5 years (2020 to 2025), iRhythm Holdings, Inc. 's debt-to-equity has grown at a 8.3% compound annual growth rate (CAGR), from 0.4× to 0.5×.
What does debt-to-equity mean?
Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.